SELLAS Life Sciences Group, Inc. (SLS)

SLS Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	65	34	49	88	55	21
Market Cap Growth	40.42%	-30.05%	-44.69%	59.80%	162.42%	-22.68%
Enterprise Value	48	32	32	67	21	14
PE Ratio	-	-0.91	-1.18	-4.24	-3.26	-0.75
PS Ratio	-	-	48.59	11.56	28.93	-
PB Ratio	6.74	-4.26	10.02	4.32	1.97	3.44
P/FCF Ratio	-1.89	-1.08	-2.04	-3.38	-5.28	-1.19
P/OCF Ratio	-1.89	-1.08	-2.04	-3.38	-5.28	-1.19
EV/Sales Ratio	-	-	32.31	8.84	10.82	-
EV/EBITDA Ratio	-1.11	-0.88	-0.79	-3.24	-1.23	-0.71
EV/EBIT Ratio	-1.09	-0.86	-0.78	-3.21	-1.23	-0.71
EV/FCF Ratio	-1.30	-1.03	-1.36	-2.58	-1.97	-0.78
Debt / Equity Ratio	0.08	-0.11	0.19	0.04	0.04	0.04
Debt / EBITDA Ratio	-0.02	-0.02	-0.02	-0.04	-0.06	-0.01
Debt / FCF Ratio	-0.03	-0.03	-0.04	-0.03	-0.10	-0.01
Quick Ratio	1.28	0.19	1.11	4.31	2.87	1.39
Current Ratio	1.49	0.23	1.14	4.63	2.99	1.56
Asset Turnover	0	0	0.04	0.21	0.08	0
Return on Equity (ROE)	-5258.30%	-2405.50%	-407.60%	-75.90%	-141.00%	-328.70%
Return on Assets (ROA)	-250.00%	-241.00%	-164.20%	-55.80%	-70.10%	-143.20%
Return on Capital (ROIC)	-345.57%	535.63%	-723.78%	-119.57%	-58.66%	-317.61%
Earnings Yield	-54.87%	-109.87%	-85.00%	-23.56%	-30.62%	-133.42%
FCF Yield	-46.04%	-92.42%	-49.00%	-29.62%	-18.95%	-84.22%
Buyback Yield / Dilution	-90.31%	-43.21%	-25.29%	-94.07%	-211.76%	-878.33%
Total Shareholder Return	-90.31%	-43.21%	-25.29%	-94.07%	-211.76%	-878.33%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).